Stem Cell Sciences receives DTI funding
Tuesday, 01 February, 2005
A consortium led by Stem Cell Sciences' UK centre has been awarded £1.2 million by the UK Department of Trade and Industry (DTI) to fund a program in drug discovery for regenerative medicine.
The consortium, which comprises Stem Cell Sciences, the Institute for Stem Cell Research at the University of Edinburgh, University College London Biochemical Engineering, GE Biosciences, Global Research Centre and the Insight Faraday Partnership, plans to develop high throughput cell screening using high density arrays of specific cell types derived from embryonic stem cells, which will be used to speed the discovery of drug based regenerative medicines.
The grant was one of three awarded to consortia of academic and industry groups in the bioprocessing sector, a key business area for funding under the DTI's Technology Programme, which aims to speed the translation of collaborative research into successful businesses.
COVID vaccine candidate protects against multiple variants
By targeting features shared by a range of coronaviruses, the vaccine is designed to offer...
Stevia leaf extract has potential as an anticancer treatment
When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic...
Even non-antibiotics can disrupt the microbiome
Many non-antibiotics inhibit useful gut bacteria, giving rise to an imbalance in the microbiome,...
